The Circadian Clock in Cancer Development and Therapy - Progress in Molecular Biology and Translational Science - page 274

302. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature . 2004;432
(7015):307-315.
303. Pan X, Zhang Y, Wang L, Hussain MM. Diurnal regulation of MTP and plasma tri-
glyceride by CLOCK is mediated by SHP. Cell Metab . 2010;12(2):174-186.
304. Liu C, Li S, Liu T, Borjigin J, Lin JD. Transcriptional coactivator PGC-1alpha inte-
grates the mammalian clock and energy metabolism. Nature . 2007;447(7143):
477-481.
305. Hofman MA, Swaab DF. Living by the clock: the circadian pacemaker in older people.
Ageing Res Rev . 2006;5(1):33-51.
306. Kondratov RV. A role of the circadian system and circadian proteins in aging. Ageing
Res Rev . 2007;6(1):12-27.
307. Asai M, Yoshinobu Y, Kaneko S, et al. Circadian profile of Per gene mRNA expression
in the suprachiasmatic nucleus, paraventricular nucleus, and pineal body of aged rats.
J Neurosci Res . 2001;66(6):1133-1139.
308. Lachman ME, Agrigoroaei S. Promoting functional health in midlife and old age: long-
term protective effects of control beliefs, social support, and physical exercise. PLoS
One . 2010;5(10):e13297.
309. Balducci L, Ershler WB. Cancer and ageing: a nexus at several levels. Nat Rev Cancer .
2005;5(8):655-662.
310. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin . 2010;60
(5):277-300.
311. Rose MR. The evolutionary biology of aging. New York: Oxford University Press.
1991. ix þ 221 pp.
312. Pleiotropy GW. Natural selection, and senescence. Evolution . 1957;11:398-411.
313. Atwood CS, Bowen RL. The reproductive-cell cycle theory of aging: an update. Exp
Gerontol . 2011;46(2-3):100-107.
314. Strehler BL. Genetic instability as the primary cause of human aging. Exp Gerontol .
1986;21(4-5):283-319.
315. Pawelec G, Derhovanessian E, Larbi A. Immunosenescence and cancer. Crit Rev Oncol
Hematol . 2010;75(2):165-172.
316. Anisimov VN, Sikora E, Pawelec G. Relationships between cancer and aging: a mul-
tilevel approach. Biogerontology . 2009;10(4):323-338.
317. Lee DJ, Cha EK, Dubin JM, et al. Novel therapeutics for the management of castration-
resistant prostate cancer (CRPC). BJU Int . 2012;109(7):968-985.
318. Minelli A, Bellezza I, Conte C, Culig Z. Oxidative stress-related aging: a role for pros-
tate cancer? Biochim Biophys Acta . 2009;1795(2):83-91.
319. Best BP. Nuclear DNA, damage as a direct cause of aging. Rejuvenation Res . 2009;12
(3):199-208.
320. Espejel S, Martin M, Klatt P, Martin-Caballero J, Flores JM, Blasco MA. Shorter telo-
meres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice.
EMBO Rep . 2004;5(5):503-509.
321. de Boer J, Andressoo JO, de Wit J, et al. Premature aging in mice deficient in DNA
repair and transcription. Science . 2002;296(5571):1276-1279.
322. Dolle ME, Busuttil RA, Garcia AM, et al. Increased genomic instability is not a pre-
requisite for shortened lifespan in DNA repair deficient mice. Mutat Res . 2006;596
(1-2):22-35.
323. Cao L, Li W, Kim S, Brodie SG, Deng CX. Senescence, aging, and malignant trans-
formation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev .
2003;17(2):201-213.
324. Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect .

1991;93:59-62.